24.10.2012 Views

Directors' Report: Governance - British American Tobacco

Directors' Report: Governance - British American Tobacco

Directors' Report: Governance - British American Tobacco

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

www.bat.com/annualreport2009<br />

policy that Non-Executive Directors do not receive additional fees for<br />

attendance at Board Committee meetings. It is expected that all Non-<br />

Executive Directors will sit on the Remuneration and the Nominations<br />

Committees and will either be a member of the Audit Committee or<br />

the Corporate Social Responsibility Committee.<br />

Non-Executive Directors’ fees (including those of the Chairman) are<br />

determined within the overall aggregate annual limit of £2,500,000<br />

authorised by shareholders with reference to the Company’s Articles<br />

of Association. The Board as a whole considers the policy and structure<br />

for the Non-Executive Directors’ fees on the recommendation of the<br />

Chairman and the Chief Executive. The Non-Executive Directors do<br />

not participate in discussions on their specific levels of remuneration.<br />

Non-Executive Directors receive no other pay or benefits (with the<br />

exception of reimbursement of expenses incurred in respect of their<br />

duties as Directors of the Company). It is the policy of the Board that<br />

the spouses of the Executive Directors and Non-Executive Directors<br />

may accompany the Directors for business purposes on designated<br />

trips and functions during the year.<br />

Anthony Ruys is a non-executive director of ITC Limited (ITC) (an<br />

associated undertaking of the Company). During the year ended<br />

31 December 2009, Anthony Ruys received INR196,712 (£2,475)<br />

in fees from ITC. This amount is the subject of an annual supplement<br />

from the Group so that he receives a total annual fee for this<br />

appointment of £75,000.<br />

Chairman’s terms of appointment and remuneration<br />

The Remuneration Committee is responsible for determining the terms<br />

of engagement and fees payable to the Chairman. This process takes<br />

into account the breadth of that role coupled with its associated levels<br />

of commitment and expertise.<br />

Jan du Plessis resigned as a Director and as Chairman of the Company<br />

on 31 October 2009. His terms of appointment provided that he held<br />

the office of Chairman with effect from 1 July 2007 for a period of<br />

three years unless terminated earlier by: (1) the Company giving three<br />

months’ notice or a discretionary compensation payment in lieu of<br />

notice; or (2) by the Chairman giving one month’s written notice with<br />

the Company having discretion to make a compensation payment in<br />

lieu of such notice. Any such compensation payment would have been<br />

limited to any fees which were payable for such part of the relevant<br />

notice period as the Board did not require the Chairman to perform<br />

his duties. Jan du Plessis did not receive any compensation payment<br />

upon his departure from the Company.<br />

Directors’ report: <strong>Governance</strong><br />

<strong>British</strong> <strong>American</strong> <strong>Tobacco</strong> Annual <strong>Report</strong> 2009<br />

The terms of Jan du Plessis’ appointment provided for: (1) an annual<br />

fee of £620,000 (from 1 April 2009); (2) the use of a driver; and<br />

(3) private medical insurance and personal accident insurance benefits.<br />

He did not participate in the <strong>British</strong> <strong>American</strong> <strong>Tobacco</strong> share schemes,<br />

bonus schemes or incentive plans and was not a member of any Group<br />

pension plan.<br />

Richard Burrows was appointed as a Director and Chairman Designate<br />

of the Company with effect from 1 September 2009 and as Chairman<br />

of the Company from 1 November 2009. The terms of his appointment<br />

provide that he holds the appointment for an initial term of two years<br />

unless terminated earlier by: (1) the Company giving three months’<br />

notice or a discretionary compensation payment in lieu of notice; or<br />

(2) by him giving one month’s written notice; with the Company<br />

having discretion to make a compensation payment in lieu of such<br />

notice. The compensation payment is limited to any fees which are<br />

payable for such part of the relevant notice period as the Board does<br />

not require him as Chairman to perform his duties.<br />

As a Director of the Company, the Chairman is subject to the<br />

reappointment of Directors provisions contained in the Company’s<br />

Articles of Association. A resolution for Richard Burrows’ reappointment<br />

as a Director will be put to the Annual General Meeting to be held on<br />

28 April 2010.<br />

The terms of Richard Burrows’ appointment provide for: (1) an annual<br />

fee of £525,000; (2) the use of a driver; (3) private medical insurance<br />

and personal accident insurance benefits; (4) the reimbursement by the<br />

Company of the cost of return airline tickets to London from Ireland<br />

in connection with his duties as Chairman; and (5) the provision by<br />

the Company of temporary accommodation in London for a maximum<br />

period of six months from the date of his appointment to the Board. In<br />

common with the Non-Executive Directors, Richard Burrows does not<br />

participate in the <strong>British</strong> <strong>American</strong> <strong>Tobacco</strong> share schemes, bonus schemes<br />

or incentive plans and is not a member of any Group pension plan.<br />

The Remuneration Committee has concluded that, as his fees had been<br />

benchmarked immediately prior to his appointment, the next review<br />

of Richard Burrows’ fees would not take place until February 2011.<br />

Copies of service contracts and terms of appointment<br />

Copies of the Executive Directors’ service contracts and the details<br />

of the terms of appointment of each Non-Executive Director and the<br />

Chairman are available for inspection during normal business hours at<br />

the Company’s registered office and will also be available for inspection<br />

at the Annual General Meeting on 28 April 2010.<br />

89<br />

From the Chairman<br />

Performance<br />

and strategy Regional review Financial review <strong>Governance</strong><br />

Group financial<br />

statements<br />

Parent Company<br />

financial statements<br />

Shareholder<br />

information

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!